ONCY:NASDAQ
Oncolytics Biotech Inc
$0.50
arrow_downward
-0.36%(-0.0018) 1D
$0.50
arrow_upward
+0.75% (+0.0037)bedtimeAfter hours
Closed: Oct 19, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$0.51
High
$0.55
Low
$0.49
Mkt. cap
64.83M
Avg. vol.
1.40M
Volume
697.04K
52-wk high
$1.32
52-wk low
$0.44
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
Open
$0.51
High
$0.55
Low
$0.49
Mkt. cap
64.83M
Avg. vol.
1.40M
Volume
697.04K
52-wk high
$1.32
52-wk low
$0.44
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
News stories
From web sources and news partners
www.tokenpost.com
·
54 minutes ago
S&P 500's Other 493 Companies Forecast to Outgrow Magnificent Seven in Q4
www.tokenpost.com
·
1 hour ago
SOX-to-S&P 500 Ratio Falls to Lowest Level Since Late April
Crypto Briefing
·
5 hours ago
AI stocks now make up 49% of the S&P 500, the second-highest concentration on record
TradingView
·
6 hours ago
The Dow Jones Index Closes 0.07% Lower
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Websiteoncolyticsbiotech.com